|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2006-10-18
|
|
pubmed:abstractText |
Exhaled nitric oxide (FeNO) has been reported to be elevated in the oxidative stress involved in asthmatic patients, and the reaction of nitric oxide (NO) with superoxide anions results in the formation of nitrotyrosine. The purpose of this study was to investigate the effect of inhaled steroid treatment on nitrotyrosine levels collected by exhaled breath condensate (EBC) and on FeNO.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/17047290-10325913,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17047290-10390403,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17047290-10445617,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17047290-10518817,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17047290-10806180,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17047290-11029330,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17047290-11153569,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17047290-11491165,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17047290-12166573,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17047290-12775861,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17047290-16275364,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17047290-2154753,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17047290-7663792,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17047290-7904001,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17047290-8131617,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17047290-8630623,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17047290-8779123,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17047290-8887607,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17047290-9707165
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0962-9351
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
2006
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
31919
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17047290-Administration, Inhalation,
pubmed-meshheading:17047290-Adolescent,
pubmed-meshheading:17047290-Anti-Asthmatic Agents,
pubmed-meshheading:17047290-Asthma,
pubmed-meshheading:17047290-Breath Tests,
pubmed-meshheading:17047290-Child,
pubmed-meshheading:17047290-Fluocinolone Acetonide,
pubmed-meshheading:17047290-Humans,
pubmed-meshheading:17047290-Lung,
pubmed-meshheading:17047290-Male,
pubmed-meshheading:17047290-Nitric Oxide,
pubmed-meshheading:17047290-Pilot Projects,
pubmed-meshheading:17047290-Respiratory Function Tests,
pubmed-meshheading:17047290-Single-Blind Method,
pubmed-meshheading:17047290-Tyrosine
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Flunisolide decreases exhaled nitric oxide and nitrotyrosine levels in asthmatic children.
|
|
pubmed:affiliation |
Department of Paediatrics, University of Verona, Verona, Italy.
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial
|
